The prolyl hydroxylase inhibitor GSK1120360A reduces early brain injury, but protection is not maintained in a neonatal rat model of hypoxic ischaemic encephalopathy
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Developmental Neuroscience"
DOI: 10.1002/jdn.10199
Abstract: Hypoxic–ischemic encephalopathy (HIE) in newborns is associated with high morbidity and mortality, with many babies suffering long‐term neurological deficits. Currently, treatment options are limited to therapeutic hypothermia, which is not appropriate for use in all… read more here.
Keywords: prolyl hydroxylase; group; brain injury; gsk1120360a ... See more keywords